Literature DB >> 31075164

Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Andrea M Weckman1,2, Chloe R McDonald2, Jo-Anna B Baxter3,4, Wafaie W Fawzi5, Andrea L Conroy2, Kevin C Kain1,2,6.   

Abstract

The available data support the hypothesis that L-arginine or L-citrulline supplementation would be suitable for implementation in resource-constrained settings and will enhance placental vascular development and improve birth outcomes. In resource-constrained settings, the rates of adverse birth outcomes, including fetal growth restriction, preterm birth, and low birth weight, are disproportionately high. Complications resulting from preterm birth are now the leading cause of mortality in children <5 y of age worldwide. Despite the global health burden of adverse birth outcomes, few effective interventions are currently available and new strategies are urgently needed, especially for low-resource settings. L-arginine is a nutritionally essential amino acid in pregnancy and an immediate precursor of nitric oxide. During pregnancy, placental and embryonic growth increases the demand for L-arginine, which can exceed endogenous synthesis of L-arginine from L-citrulline, necessitating increased dietary intake. In many low-resource settings, dietary intake of L-arginine in pregnancy is inadequate owing to widespread protein malnutrition and depletion of endogenous L-arginine due to maternal infections, in particular malaria. Here we examine the role of the L-arginine-nitric oxide biosynthetic pathway in pregnancy including placental vascular development and fetal growth. We review the evidence for the relations between altered L-arginine bioavailability and pregnancy outcomes, and strategies for arginine supplementation in pregnancy. Existing studies of L-arginine supplementation in pregnancy in high-resource settings have shown improved maternal and fetal hemodynamics, prevention of pre-eclampsia, and improved birth outcomes including higher birth weight and longer gestation. Arginine supplementation studies now need to be extended to pregnant women in low-resource settings, especially those at risk of malaria.
Copyright © American Society for Nutrition 2019.

Entities:  

Keywords:  L-arginine; L-citrulline; amino acid; birth outcomes; low- and middle-income countries; maternal malnutrition; nitric oxide; placental vasculature; pregnancy; supplementation

Mesh:

Substances:

Year:  2019        PMID: 31075164      PMCID: PMC6743852          DOI: 10.1093/advances/nmz015

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  127 in total

Review 1.  Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis.

Authors:  A Conde-Agudelo; A T Papageorghiou; S H Kennedy; J Villar
Journal:  BJOG       Date:  2013-02-11       Impact factor: 6.531

2.  Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.

Authors:  S A Fickling; D Williams; P Vallance; S S Nussey; G S Whitley
Journal:  Lancet       Date:  1993-07-24       Impact factor: 79.321

3.  Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast.

Authors:  K A Groesch; R J Torry; A C Wilber; R Abrams; A Bieniarz; L J Guilbert; D S Torry
Journal:  Placenta       Date:  2011-09-29       Impact factor: 3.481

4.  Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta.

Authors:  W G Rossmanith; U Hoffmeister; S Wolfahrt; B Kleine; M McLean; R A Jacobs; A B Grossman
Journal:  Mol Hum Reprod       Date:  1999-05       Impact factor: 4.025

5.  Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation.

Authors:  J Dötsch; N Hogen; Z Nyúl; J Hänze; I Knerr; M Kirschbaum; W Rascher
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-08       Impact factor: 2.435

6.  Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia.

Authors:  K Rytlewski; R Olszanecki; R Korbut; Z Zdebski
Journal:  Eur J Clin Invest       Date:  2005-01       Impact factor: 4.686

7.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

8.  Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine).

Authors:  P Sieroszewski; J Suzin; A Karowicz-Bilińska
Journal:  J Matern Fetal Neonatal Med       Date:  2004-06

9.  S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion.

Authors:  Lynda K Harris; James McCormick; Judith E Cartwright; Guy St J Whitley; Philip R Dash
Journal:  Exp Cell Res       Date:  2008-02-29       Impact factor: 3.905

Review 10.  Energy and protein intake in pregnancy.

Authors:  M S Kramer; R Kakuma
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  9 in total

1.  Prenatal Amino Acid Supplementation to Improve Fetal Growth: A Systematic Review and Meta-Analysis.

Authors:  Fieke Terstappen; Angela J C Tol; Hendrik Gremmels; Kimberley E Wever; Nina D Paauw; Jaap A Joles; Eline M van der Beek; A Titia Lely
Journal:  Nutrients       Date:  2020-08-21       Impact factor: 5.717

2.  Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma.

Authors:  Sonia T Anand; Kelli K Ryckman; Rebecca J Baer; Mary E Charlton; Patrick J Breheny; William W Terry; Kord Kober; Scott Oltman; Elizabeth E Rogers; Laura L Jelliffe-Pawlowski; Elizabeth A Chrischilles
Journal:  J Matern Fetal Neonatal Med       Date:  2021-05-12

Review 3.  Placental Impact of Dietary Supplements: More Than Micronutrients.

Authors:  Aisha Rasool; Fernanda Alvarado-Flores; Perrie O'Tierney-Ginn
Journal:  Clin Ther       Date:  2020-12-23       Impact factor: 3.393

Review 4.  Poor Birth Outcomes in Malaria in Pregnancy: Recent Insights Into Mechanisms and Prevention Approaches.

Authors:  Caroline L L Chua; Wina Hasang; Stephen J Rogerson; Andrew Teo
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

Review 5.  A review of the amino acid metabolism in placental function response to fetal loss and low birth weight in pigs.

Authors:  Chengquan Tan; Zihao Huang; Wenyu Xiong; Hongxuan Ye; Jinping Deng; Yulong Yin
Journal:  J Anim Sci Biotechnol       Date:  2022-03-02

Review 6.  Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia.

Authors:  Ana C Palei; Joey P Granger; Frank T Spradley
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

7.  RNA-seq reveals insights into molecular mechanisms of metabolic restoration via tryptophan supplementation in low birth weight piglet model.

Authors:  Ping Xiao; Parniyan Goodarzi; Adel Pezeshki; Darren E Hagen
Journal:  J Anim Sci       Date:  2022-05-01       Impact factor: 3.338

8.  Evaluation of the predictive values of elevated serum L-homoarginine and dimethylarginines in preeclampsia.

Authors:  Xiangmei Yuan; Leiming Cai; Fengmei Hu; Li Xie; Xiong Chen; Jingjing Wu; Qian Li
Journal:  Amino Acids       Date:  2022-06-26       Impact factor: 3.789

Review 9.  Placental Angiogenesis in Mammals: A Review of the Regulatory Effects of Signaling Pathways and Functional Nutrients.

Authors:  Zihao Huang; Shuangbo Huang; Tongxing Song; Yulong Yin; Chengquan Tan
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.